Question explored with the scientific record
Conversation so far
- 1 what are the instances and longevity of long covid recovery + a private exchange
- 2 long covid has been around for years, why aren't there more cases of proven recovery + a private exchange
- 3 The mechanism matters here. Small fiber neuropathy means the nerves themselves are dying back. Retinal thinning means brain tissue has been lost. EMG abnormalities mean the connection between nerve and muscle is broken. None of these heal quickly, and some do not heal at all. The body does not reliably regenerate nerve fibers the way it repairs a cut. elaborate
- 4 Which treatments have evidence of slowing or reversing small fiber loss?
Answered on this page ↓
Which treatments have evidence of slowing or reversing small fiber loss?
The short version: no treatment in this evidence base has been shown to reverse small fiber loss. The best documented option reduces pain and may support regrowth, but the proof is thin.
The evidence here is mostly about diagnosis, not treatment. One review confirms that skin biopsy with nerve fiber density is the gold standard for detecting the loss [3]. Another shows that immune-mediated causes are more common in the non-length-dependent form, which matters because it points to which treatments might work [3, 5]. But none of that tells you what reverses the damage.
The one treatment with real data is high-concentration capsaicin cream for diabetic peripheral neuropathy. A single-center trial found that after three months, patients using it had higher epidermal nerve fiber densities on biopsy [12]. That is actual regrowth, not just pain relief. The same review reports that regenerating fibers appear around three weeks after treatment, with fuller regrowth over 12 to 24 weeks [12]. Pain reduction was substantial: about 34 in 100 people got meaningful relief after the first application, rising to about 77 in 100 after the seventh [12]. But the larger trials were funded by the manufacturer, and the primary endpoint was quality of life, not nerve regrowth [12]. The biopsy evidence comes from small, single-center studies.
For immune-mediated small fiber neuropathy, one case report shows intravenous immunoglobulin took a patient with Sjögren's syndrome from severe burning pain to zero pain over three treatments [6]. That is a single patient, not a trial. It suggests the immune route is worth investigating, but it proves nothing on its own.
| Treatment | Pain relief | Nerve regrowth evidence | Study quality |
|---|---|---|---|
| High-concentration capsaicin | 77 in 100 after 7 applications [12] | Increased fiber density at 3 months [12] | Manufacturer-funded trials; small biopsy studies |
| IVIG for Sjögren's SFN | Pain to zero in 1 case [6] | Not measured | Single case report |
The honest gap: no trial here compared treated patients to untreated patients over years with repeat skin biopsies. That is the study design that would actually show whether small fiber loss can be reversed. It has not been run in this evidence base.
My call: capsaicin cream is the only treatment here with any evidence of supporting nerve regrowth, and that evidence is modest and conflicted. Confidence: low.
Sources used 4
-
Small Fiber Neuropathy
This is a clinical review article summarizing the clinical features, diagnostic evaluation, associated conditions, and management of small fiber neuropathy (SFN), emphasizing skin biopsy with intraepidermal nerve fiber density (IENFD) evaluation as the gold standard for diagnosi…
DOI: 10.1055/s-0039-1688977 -
Non‐length‐dependent small fiber neuropathy: Not a matter of stockings and gloves
A comprehensive narrative review detailing non-length-dependent small fiber neuropathy (NLD-SFN): its definition, ganglionopathy-like pathophysiology, clinical features, associated conditions, diagnostic approaches (skin biopsy IENFD, QST, autonomic testing, CCM, MRI), and curre…
DOI: 10.1002/mus.27379 -
Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjögren’s syndrome
This study presents a case of a 40-year-old woman with small fiber neuropathy associated with primary Sjögren's syndrome who experienced immediate and significant relief from severe burning pain following intravenous immunoglobulin therapy, suggesting an immune-mediated mechanis…
DOI: 10.3109/s10165-009-0180-2 -
Diabetic Peripheral Neuropathy: Pathophysiology and New Insights into the Mechanism of Action of High-Concentration Topical Capsaicin
This review summarizes the pathophysiology of diabetic peripheral neuropathy and the proposed regenerative mechanism of action of high-concentration topical capsaicin, compiling clinical trial and skin-biopsy evidence that repeated HCCTS applications may reduce pain and promote …
DOI: 10.2147/jep.s526968